Matrix metalloproteinases are a biologically plausible and promising biomarker for rapid disease progression in ADPKD and CKD in general. Matrix metalloproteinases may predict rapid disease ...
Tolvaptan’s effect on total kidney volume and eGFR decline diminished with increasing visceral adiposity. Visceral adiposity independently predicts rapid kidney growth and lower tolvaptan efficacy in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results